First human trial tests new radiation poisoning treatment
NCT ID NCT05628961
Summary
This first-in-human study tested the safety of a new oral drug called HOPO 14-1 in 42 healthy volunteers. The drug is being developed to help remove radioactive materials from the body after accidental contamination. Researchers gave participants single doses of the capsules to check for side effects and see how the body processes the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOXICITY;CHEMICAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SRI International Clinical Trials Unit
Plymouth, Michigan, 48170, United States
Conditions
Explore the condition pages connected to this study.